Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Adeno-associated virus-2 (AAV-2)-mediated gene therapy is quite suitable for local or regional application in head and neck cancer squamous cell carcinoma (HNSCC). However, its low transduction efficiency has limited its further deve...
Main Authors: | Liu Yanxin, Liu Shilian, Ma Hong, Xiang Yang, Liu Zheng, Jiang Minghong, Zheng Dexian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/54 |
Similar Items
-
Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice
by: Zheng Liu, et al.
Published: (2012-04-01) -
HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species.
by: Dan-Ming Zhu, et al.
Published: (2011-01-01) -
Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma.
by: Chi T Viet, et al.
Published: (2014-01-01) -
Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
by: Shutong Liu, et al.
Published: (2017-09-01) -
Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
by: Alexandre Arthur Jacinto, et al.
Published: (2018-10-01)